Display options
Cite
Haddad M, Popovtzer R, Yariv I, et al. [CONCISE NANOMEDICINE REVIEW]. Harefuah. 2018;157(4):232-236
Haddad, M., Popovtzer, R., Yariv, I., Motiei, M., & Fixler, D. (2018). [CONCISE NANOMEDICINE REVIEW]. Harefuah, 157(4), 232-236.
Haddad, Menashe, et al. "[CONCISE NANOMEDICINE REVIEW]." Harefuah vol. 157,4 (2018): 232-236.
Haddad M, Popovtzer R, Yariv I, Motiei M, Fixler D. [CONCISE NANOMEDICINE REVIEW]. Harefuah. 2018 Apr;157(4):232-236. Hebrew. PMID: 29688641.
Copy Download .nbib Format: NLM
Share it on

Harefuah. 2018 Apr;157(4):232-236.

[CONCISE NANOMEDICINE REVIEW].

Harefuah

[Article in Hebrew]
Menashe Haddad, Rachela Popovtzer, Inbar Yariv, Menachem Motiei, Dror Fixler

Affiliations

  1. Sackler Faculty of Medicine, Tel-Aviv University.
  2. Mayanei Hayeshua Medical Center.
  3. Faculty of Engineering and Institute of Nanotechnology and Advanced Materials, Bar-Ilan University.

PMID: 29688641

Abstract

INTRODUCTION: Nanomedicine is a rapidly evolving medical domain utilizing 1-100nm nanoscale particles to achieve medical goals in either one or more medical aspects - diagnosis, imaging and therapy. Nanomedicine employs a combination of methods stemming from life and exact sciences. This review deals briefly with the principles behind the scenes guiding the design, manufacture and employment of these nanoparticles. Some representative examples of the various applications are provided from the abundance of existing nanoparticles. The main topics discussed are those related to composition, characteristics of nanoparticles, usage in cancer, drug delivery and various central nervous system applications. Possible toxicity and future teratogenicity research pertaining to nanoparticles are also elaborated upon.

MeSH terms

Publication Types